Arbutus Biopharma Aktie
2,91
EUR
-0,20
EUR
-6,37
%
3,24
USD
-0,28
USD
-7,97
%
Werbung
Arbutus Biopharma Aktie Analyse
15.10.18 | Arbutus Biopharma Neutral | Wedbush Morgan Securities Inc. | |
06.07.18 | Arbutus Biopharma Neutral | B. Riley FBR, Inc. | |
19.03.18 | Arbutus Biopharma Neutral | Wedbush Morgan Securities Inc. | |
13.12.16 | Arbutus Biopharma Neutral | Chardan Capital Markets | |
14.10.16 | Arbutus Biopharma Neutral | Chardan Capital Markets | |
16.06.16 | Arbutus Biopharma Neutral | Chardan Capital Markets |
Werbung
Werbung